Evidence map›Paper›PMID 41446211›Full record

ArticlebioRxiv : the preprint server for biology2025

A Model for the Diversity Explosion Fundamental to Metastasis.

Edward Tim O'Brien

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Edward Tim O'BrienDepartment of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Laura Fish · 1985 to 2026
$174.8M
Super-resolution Imaging via Multiple Modalities with the Zeiss Elyra 7S10OD028703 · OD · DUKE UNIVERSITY · PI SODERLING, SCOTT H · 2020 to 2020
$695k
NCI NIH HHS P30 CA014236NIH HHS S10 OD028703
6 · The paper itself

Abstract

Most deaths from cancer are caused by their metastases. Along with the ability to evade the immune system and to invade and disrupt very different tissue environments, metastases usually develop resistance to whatever therapeutic approaches are tried. Their extreme adaptability requires a diversity of traits from which natural selection can choose, but current models, such as the epithelial-to-mesenchymal transition (EMT), do not directly address how this diversity is generated. We observed that single cell clones of Panc1 human pancreas cancer cells that had had crispR knock outs (KO) of the gene for activin-like kinase 4 (ALK4) had developed a markedly diverse morphology. Time-lapse and fluorescence microscopy, FACS analysis and mitotic chromosome squashes provided evidence that the cells diversify profoundly in size, behavior and chromosome number. This diversity appears to develop through cytokinesis failure, the generation of very large multinuclear cells that exhibit a high range of nuclear configurations, coupled with continued cell divisions that sometimes generate three, four, and more daughter cells in one cell division. This astounding activity often resulted in cells that were much smaller than the normal Panc1 cells, and indirect evidence suggests they were significantly sub-ploidy, yet underwent regular cell divisions. A subset of the smaller cells were highly motile, and were observed to sometimes merge together or even into larger cells. This phenomenon could provide an unappreciated venue for transferring mutated genes, chromosome fragments, whole chromosomes or sets of chromosomes into an invaded cell. We suggest that these observations may be a serendipitous illustration of the missing link between the genetic mutations implicated in the development of primary carcinoma, and the extreme genomic diversity that characterizes malignant metastases.

Identifiers

PMID41446211
PMCPMC12724465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.